XML 41 R32.htm IDEA: XBRL DOCUMENT v3.7.0.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
1 Months Ended 2 Months Ended 3 Months Ended
Oct. 02, 2016
Oct. 25, 2017
Jun. 30, 2016
May 31, 2016
Dec. 31, 2015
Jan. 31, 2015
Sep. 30, 2014
Aug. 31, 2012
Mar. 31, 2017
Mar. 31, 2017
Mar. 31, 2016
Operating lease periodic payment     $ 709     $ 730          
Frequency of periodic payment     Monthly     Monthly          
Operating lease rental expense                   $ 2,126 $ 0
Operating lease expiration date           Nov. 30, 2015          
SkyPharm [Member]                      
Operating lease periodic payment             $ 4,802        
Operating lease rental expense                   24,891 16,957
Term of operating lease             6 years        
SkyPharm [Member] | Additional space [Member]                      
Operating lease periodic payment     $ 2,021 $ 886              
SkyPharm [Member] | First Floor [Member]                      
Operating lease periodic payment         $ 886            
Amplerissimo [Member]                      
Operating lease periodic payment               $ 122      
Frequency of periodic payment               Monthly      
Operating lease rental expense                   $ 352 $ 364
Operating lease expiration date               Jul. 31, 2013      
Operating lease renewal date               Jul. 31, 2015      
Intellectual property sale agreement [Member] | Anastasios Tsekas and Olga Parthenea Georgatsou [Member]                      
Operating lease periodic payment $ 1,500                    
Common stock shares reserved 2,000,000                    
Intellectual property sale agreement [Member] | Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Conclusion of Phase III testing [Member]                      
Common stock shares reserved 500,000                    
Intellectual property sale agreement [Member] | Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | conclusion of Phase I testing [Member]                      
Common stock shares reserved 500,000                    
Intellectual property sale agreement [Member] | Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Conclusion of Phase II testing [Member]                      
Common stock shares reserved 500,000                    
Intellectual property sale agreement [Member] | Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Conclusion of Preclinical Trials [Member]                      
Common stock shares reserved 500,000                    
Decahedron [member]                      
Operating lease periodic payment   $ 2,366                  
Operating lease rental expense                 $ 4,729    
Term of operating lease   1 year